PF-1803

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NamePF-1803
Drug Alias NamePF-1803
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAnti-Osteoclast-associated immunoglobulin-like receptorGlucagon-like peptide 1 receptor agonists
TargetsOsteoclast-associated immunoglobulin-like receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoForge Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunoForge Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A